Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (83)
- Scheduling (national classification system) (11)
- Manufacturing (10)
- Fees and payments (4)
- Safety monitoring and information (4)
- COVID-19 (3)
- Clinical trials (1)
- Import and export (1)
- Labelling and packaging (1)
- Legislation (1)
- Metal-on-metal hip replacement implants hub (1)
- Shortages and supply disruptions (1)
- Unique Device Identification (UDI) hub (1)
Search
202 result(s) found, displaying 101 to 125
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Corporate reportsGuidance for reducing assessment fees for ARTG application audits and TGA conformity assessments of medical devices (including IVDs).
-
Corporate reportsStatistical information for 1 July to 31 December 2019 in relation to our regulation of therapeutic goods
-
Corporate reportsIn 2019, the TGA conducted 10 pharmacovigilance inspections of Australian medicine sponsors
-
Corporate reportsThis report describes the first 12 months of the mandatory reporting scheme
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper.
-
Corporate reportsThe Health Products Regulation Group has published a new regulatory science strategy
-
Corporate reportsOur plan for how HPRG will maintain and build its regulatory science capability over the next 5 years
-
Corporate reportsThe TGA has finalised the outcomes of the Lower Risk Registered OTC Products Review Pilot Project
-
Corporate reportsTGA instructions for disinfectant testing.
-
Corporate reportsTargets have been met for most measures under the six KPIs
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper.
-
Corporate reportsWe thank respondents who provided a submission in response to the public consultation paper, regulation of software, including Software as a Medical Device (SaMD).
-
Corporate reportsWe thank respondents who provided a submission in response to the public consultation paper.
-
Corporate reportsPublication of submissions to the public consultation paper proposed changes to the classification of active implantable medical devices and their accessories.
-
Corporate reportsPublication of submissions to the public consultation paper proposed changes to the classification of medical devices used in direct contact with the heart, central circulatory or central nervous systems.
-
Corporate reportsPublication of submissions to the public consultation paper potential reclassification of active medical devices for diagnosis and patient therapy.
-
Corporate reportsPublication of submissions to the public consultation paper proposed new classification rule for medical devices that administer medicines or biologicals by inhalation.
-
Corporate reportsPublication of submissions to the public consultation paper proposed reclassification of spinal implantable medical devices.
-
Corporate reportsThe 2018-19 Annual Performance Statistics Report is now available
-
Corporate reportsProfessor McMillan's Final Report on the Review of the Act was tabled in Parliament on Thursday 5 September 2019
-
Corporate reportsSubmissions received on the Proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia have been published.